![John Maslowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Maslowski
Amministratore Delegato presso
Forge Biologics, Inc.
Patrimonio netto: - $ in data 31/05/2026
Profilo
John M.
Maslowski is currently President, Chief Executive Officer & Director at Forge Biologics, Inc. since 2024.
He is Director at Nionyx Bio, Inc. starting in 2025, Director at Dystrophic Epidermolysis Bullosa Research Association of America, Inc. since 2024, and Independent Director at Research Alliance Corp.
IV.
Formerly, Mr. Maslowski was President & Chief Executive Officer at Fibrocell Science, Inc. from 2019 to 2020.
He was Director at Alliance for Regenerative Medicine from 2019 to 2024.
He served as Manager-Quality Assurance Investigations at Wyeth Pharmaceuticals LLC in 2005.
He was Chief Operating Officer at Castle Creek Biosciences, Inc. from 2016 to 2021.
Education includes undergraduate studies at Ursinus College and graduate studies at Villanova University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
2,27% | 10/07/2026 | 30.000 ( 2,27% ) | 0 $ | 31/05/2026 |
Posizioni attive di John Maslowski
| Società | Posizione | Inizio |
|---|---|---|
Forge Biologics, Inc.
 Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Amministratore Delegato | 01/10/2024 |
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc.
 Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides care and support services for people living with epidermolysis bullosa | Direttore/Membro del Consiglio | 01/07/2024 |
Precedenti posizioni note di John Maslowski
| Società | Posizione | Fine |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direttore/Membro del Consiglio | 01/12/2024 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Amministratore Delegato | 20/04/2021 |
| FIBROCELL SCIENCE, INC. | Amministratore Delegato | 01/01/2020 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | 01/01/2005 |
Formazione di John Maslowski
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Ursinus College
 Ursinus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc.
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides care and support services for people living with epidermolysis bullosa | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Forge Biologics, Inc.
Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Health Technology |
